tiprankstipranks
Trending News
More News >
ExpreS2ion Biotech Holding AB (DE:5JD0)
FRANKFURT:5JD0
Germany Market

ExpreS2ion Biotech Holding AB (5JD0) Ratios

Compare
2 Followers

ExpreS2ion Biotech Holding AB Ratios

DE:5JD0's free cash flow for Q4 2024 was kr-2.57. For the 2024 fiscal year, DE:5JD0's free cash flow was decreased by kr and operating cash flow was kr-32.21. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
2.48 6.03 4.20 19.63 6.18
Quick Ratio
2.48 6.03 4.20 19.63 6.18
Cash Ratio
2.13 5.06 3.53 4.97 5.87
Solvency Ratio
-0.87 -6.74 -3.45 -3.63 -1.18
Operating Cash Flow Ratio
-0.89 -8.86 -3.17 -6.12 -1.00
Short-Term Operating Cash Flow Coverage
-94.24 -366.86 -56.50 -23.80 -9.62
Net Current Asset Value
kr 54.87Mkr 55.34Mkr 97.91Mkr 134.85Mkr 88.15M
Leverage Ratios
Debt-to-Assets Ratio
<0.01 0.02 0.01 0.01 0.02
Debt-to-Equity Ratio
<0.01 0.03 0.02 0.01 0.03
Debt-to-Capital Ratio
<0.01 0.03 0.02 0.01 0.02
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.62 1.20 1.33 1.08 1.26
Debt Service Coverage Ratio
-51.69 -120.99 -44.24 -22.31 -4.66
Interest Coverage Ratio
-93.12 -211.51 -146.51 0.00 -8.83
Debt to Market Cap
0.01 <0.01 <0.01 <0.01 <0.01
Interest Debt Per Share
0.64 1.92 2.89 2.38 12.37
Net Debt to EBITDA
1.26 0.55 0.88 0.76 3.67
Profitability Margins
Gross Profit Margin
-88.55%48.27%0.10%38.59%-16.03%
EBIT Margin
-1454.90%-1410.87%-2471.69%-388.39%-596.88%
EBITDA Margin
-2135.41%-1453.23%-2447.78%-379.09%-541.41%
Operating Profit Margin
-2246.76%-1503.05%-2508.97%-395.59%-593.19%
Pretax Profit Margin
-1479.02%-1417.97%-2488.81%-388.39%-664.06%
Net Profit Margin
-1208.60%-1296.47%-2331.99%-359.04%-603.02%
Continuous Operations Profit Margin
-1943.58%-1296.47%-2331.99%-359.04%-603.02%
Net Income Per EBT
81.72%91.43%93.70%92.44%90.81%
EBT Per EBIT
65.83%94.34%99.20%98.18%111.95%
Return on Assets (ROA)
-34.84%-116.15%-86.34%-28.91%-26.68%
Return on Equity (ROE)
-56.53%-139.83%-114.79%-31.30%-33.54%
Return on Capital Employed (ROCE)
-102.13%-157.43%-120.45%-33.49%-31.00%
Return on Invested Capital (ROIC)
-83.00%-143.35%-111.02%-30.56%-27.63%
Return on Tangible Assets
-35.54%-119.92%-88.24%-29.52%-27.63%
Earnings Yield
-104.54%-93.87%-19.01%-3.80%-15.60%
Efficiency Ratios
Receivables Turnover
0.60 0.00 0.00 1.72 0.00
Payables Turnover
0.67 1.99 0.42 4.46 2.94
Inventory Turnover
0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
1.96 3.99 5.59 10.12 4.06
Asset Turnover
0.03 0.09 0.04 0.08 0.04
Working Capital Turnover Ratio
0.05 0.09 0.04 0.10 0.11
Cash Conversion Cycle
68.92 -183.85 -872.95 130.12 -124.30
Days of Sales Outstanding
612.86 0.00 0.00 211.98 0.00
Days of Inventory Outstanding
0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
543.93 183.85 872.95 81.86 124.30
Operating Cycle
612.86 0.00 0.00 211.98 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
-20.06 -87.45 -105.58 -56.62 -38.01
Free Cash Flow Per Share
-20.58 -89.19 -105.99 -57.50 -39.86
CapEx Per Share
0.51 1.75 0.41 0.89 1.85
Free Cash Flow to Operating Cash Flow
1.03 1.02 1.00 1.02 1.05
Dividend Paid and CapEx Coverage Ratio
-39.00 -50.07 -260.09 -63.84 -20.54
Capital Expenditure Coverage Ratio
-39.00 -50.07 -260.09 -63.84 -20.54
Operating Cash Flow Coverage Ratio
-94.24 -58.96 -53.82 -23.80 -7.64
Operating Cash Flow to Sales Ratio
-11.26 -14.31 -19.59 -3.73 -3.46
Free Cash Flow Yield
-99.90%-105.68%-16.03%-4.01%-9.38%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-0.96 -1.07 -5.26 -26.31 -6.41
Price-to-Sales (P/S) Ratio
11.56 13.81 122.65 94.48 38.65
Price-to-Book (P/B) Ratio
0.54 1.49 6.04 8.24 2.15
Price-to-Free Cash Flow (P/FCF) Ratio
-1.00 -0.95 -6.24 -24.93 -10.66
Price-to-Operating Cash Flow Ratio
-1.03 -0.97 -6.26 -25.32 -11.18
Price-to-Earnings Growth (PEG) Ratio
0.01 0.03 -0.04 1.46 -0.10
Price-to-Fair Value
0.54 1.49 6.04 8.24 2.15
Enterprise Value Multiple
0.72 -0.40 -4.13 -24.16 -3.47
Enterprise Value
-46.35M 41.49M 514.70M 1.12B 98.82M
EV to EBITDA
0.72 -0.40 -4.13 -24.16 -3.47
EV to Sales
-15.38 5.88 101.20 91.60 18.79
EV to Free Cash Flow
1.33 -0.40 -5.15 -24.17 -5.18
EV to Operating Cash Flow
1.37 -0.41 -5.17 -24.55 -5.44
Tangible Book Value Per Share
38.10 54.51 106.39 170.18 189.15
Shareholders’ Equity Per Share
38.10 56.66 109.52 174.08 197.73
Tax and Other Ratios
Effective Tax Rate
0.18 0.09 0.06 0.08 0.09
Revenue Per Share
1.78 6.11 5.39 15.17 11.00
Net Income Per Share
-21.54 -79.22 -125.71 -54.48 -66.32
Tax Burden
0.82 0.91 0.94 0.92 0.91
Interest Burden
1.02 1.01 1.01 1.00 1.11
Research & Development to Revenue
8.85 7.29 14.02 0.80 0.04
SG&A to Revenue
0.00 0.00 0.00 0.29 4.08
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
0.50 1.10 0.78 0.94 0.58
Currency in SEK
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis